DD154608A5 - Verfahren zur herstellung von 1x oxo-1h-thiazolo-[3,2-a]pyrimidin-carboxamiden u.deren zwischenstufen - Google Patents

Verfahren zur herstellung von 1x oxo-1h-thiazolo-[3,2-a]pyrimidin-carboxamiden u.deren zwischenstufen Download PDF

Info

Publication number
DD154608A5
DD154608A5 DD80225391A DD22539180A DD154608A5 DD 154608 A5 DD154608 A5 DD 154608A5 DD 80225391 A DD80225391 A DD 80225391A DD 22539180 A DD22539180 A DD 22539180A DD 154608 A5 DD154608 A5 DD 154608A5
Authority
DD
German Democratic Republic
Prior art keywords
oxo
pyrimidine
ethyl
compound
mmol
Prior art date
Application number
DD80225391A
Other languages
German (de)
English (en)
Inventor
Saul B Kadin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD154608A5 publication Critical patent/DD154608A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DD80225391A 1979-11-23 1980-11-21 Verfahren zur herstellung von 1x oxo-1h-thiazolo-[3,2-a]pyrimidin-carboxamiden u.deren zwischenstufen DD154608A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9663179A 1979-11-23 1979-11-23

Publications (1)

Publication Number Publication Date
DD154608A5 true DD154608A5 (de) 1982-04-07

Family

ID=22258306

Family Applications (1)

Application Number Title Priority Date Filing Date
DD80225391A DD154608A5 (de) 1979-11-23 1980-11-21 Verfahren zur herstellung von 1x oxo-1h-thiazolo-[3,2-a]pyrimidin-carboxamiden u.deren zwischenstufen

Country Status (35)

Country Link
JP (1) JPS5687586A (es)
KR (1) KR830004322A (es)
AR (2) AR228859A1 (es)
AT (1) AT380883B (es)
AU (1) AU520995B2 (es)
BE (1) BE886319A (es)
CA (1) CA1143731A (es)
CH (1) CH649299A5 (es)
CS (1) CS241476B2 (es)
DD (1) DD154608A5 (es)
DE (2) DE3050491C2 (es)
DK (1) DK151811C (es)
EG (1) EG14929A (es)
ES (1) ES8203363A1 (es)
FI (1) FI67706C (es)
FR (1) FR2470132A1 (es)
GB (1) GB2063862B (es)
GR (1) GR72132B (es)
GT (1) GT198066458A (es)
HU (1) HU179091B (es)
IE (1) IE50404B1 (es)
IL (1) IL61535A (es)
IN (1) IN154926B (es)
IT (1) IT1209373B (es)
LU (1) LU82950A1 (es)
NL (1) NL182565C (es)
NO (1) NO803521L (es)
NZ (1) NZ195596A (es)
PH (1) PH16666A (es)
PL (1) PL132354B1 (es)
PT (1) PT72090B (es)
SE (1) SE448732B (es)
SU (1) SU1042620A3 (es)
YU (1) YU41953B (es)
ZA (1) ZA807293B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8300728D0 (en) * 1983-01-12 1983-02-16 Erba Farmitalia Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
GB8422916D0 (en) * 1984-09-11 1984-10-17 May & Baker Ltd Compositions of matter
JP2690742B2 (ja) * 1987-03-30 1997-12-17 第一製薬株式会社 複素環アミン誘導体
ES2087072T3 (es) * 1988-03-28 1996-07-16 Janssen Pharmaceutica Nv Agentes para conservar o restablecer la salud de la piel.
TWI500623B (zh) * 2009-10-13 2015-09-21 Torrent Pharmaceuticals Ltd 新穎稠合噻唑及噁唑嘧啶酮

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1331059A (en) 1971-04-19 1973-09-19 Lilly Industries Ltd Pyrimidotriazinone compounds
US4041163A (en) * 1976-03-29 1977-08-09 Pfizer Inc. N-(5-Tetrazolyl)-4-oxo-4H-pyrimido(2,1-b)benzothiazole-3-carboxamide antiallergy agents
DE2810863A1 (de) * 1978-03-13 1979-09-27 Boehringer Mannheim Gmbh 1-oxo-1h-pyrimido eckige klammer auf 6,1-b eckige klammer zu benzthiazol-derivate und verfahren zu ihrer herstellung
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones

Also Published As

Publication number Publication date
JPS5687586A (en) 1981-07-16
FR2470132A1 (fr) 1981-05-29
GB2063862B (en) 1983-06-22
DE3043979A1 (de) 1981-09-03
PL228008A1 (es) 1981-12-11
HU179091B (en) 1982-08-28
NL182565C (nl) 1988-04-05
SE448732B (sv) 1987-03-16
DK151811B (da) 1988-01-04
NL8006362A (nl) 1981-06-16
AR228859A1 (es) 1983-04-29
ATA570780A (de) 1985-12-15
CH649299A5 (fr) 1985-05-15
ES497066A0 (es) 1982-04-01
CS782080A2 (en) 1985-06-13
YU295080A (en) 1983-06-30
IL61535A0 (en) 1980-12-31
FI803628L (fi) 1981-05-24
SE8008189L (sv) 1981-05-24
FI67706B (fi) 1985-01-31
FR2470132B1 (es) 1983-07-29
GB2063862A (en) 1981-06-10
AR231296A1 (es) 1984-10-31
BE886319A (fr) 1981-05-25
NO803521L (no) 1981-05-25
PT72090A (en) 1980-12-01
GT198066458A (es) 1982-05-15
PL132354B1 (en) 1985-02-28
JPS617432B2 (es) 1986-03-06
IL61535A (en) 1984-06-29
EG14929A (en) 1989-01-30
NL182565B (nl) 1987-11-02
IN154926B (es) 1984-12-22
DK151811C (da) 1988-06-06
AT380883B (de) 1986-07-25
CS241476B2 (en) 1986-03-13
PT72090B (en) 1981-09-29
SU1042620A3 (ru) 1983-09-15
KR830004322A (ko) 1983-07-09
IE802418L (en) 1981-05-23
DK413180A (da) 1981-05-24
DE3043979C2 (de) 1986-08-21
FI67706C (fi) 1985-05-10
ES8203363A1 (es) 1982-04-01
IT1209373B (it) 1989-07-16
CA1143731A (en) 1983-03-29
GR72132B (es) 1983-09-19
IT8026176A0 (it) 1980-11-21
DE3050491C2 (de) 1985-10-10
NZ195596A (en) 1984-05-31
AU520995B2 (en) 1982-03-11
IE50404B1 (en) 1986-04-16
PH16666A (en) 1983-12-13
LU82950A1 (fr) 1981-06-04
AU6459580A (en) 1981-05-28
ZA807293B (en) 1981-12-30
YU41953B (en) 1988-02-29

Similar Documents

Publication Publication Date Title
EP0002482B1 (de) 4-Hydroxy-2H-1,2-benzothiazin-3-carboxamid-1,1-dioxide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2740588A1 (de) Imidazo- eckige klammer auf 1,2-a eckige klammer zu -chinolin-2-carbon- saeuren und deren derivate sowie pharmazeutische zubereitungen, die diese verbindungen enthalten
HU188852B (en) Process for producing thiazolidine derivatives active against gastric ulcer and intestinal ulcer
CH641460A5 (de) Azolopyrimidinone und verwandte verbindungen.
EP0185909B1 (de) 5-Alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2634903A1 (de) Neue thienopyridinderivate und sie enthaltende arzneimittel
DD154608A5 (de) Verfahren zur herstellung von 1x oxo-1h-thiazolo-[3,2-a]pyrimidin-carboxamiden u.deren zwischenstufen
DE2258318A1 (de) Neue organische verbindungen und verfahren zu deren herstellung
DE2344611A1 (de) 5-(substituierte phenoxy)-4-aminound -substituierte aminopyrimidine
US4423048A (en) Antiallergic and antiulcer 1-oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides and intermediates therefor
US4535081A (en) Antiallergic and antiulcer 1-oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides and intermediates therefor
DE60207273T2 (de) Aminopyrrolverbindungen als entzündungshemmende Wirkstoffe
DE2404050A1 (de) Neue heterocyclische vrbindungen und verfahren zu deren herstellung
DE2630469C2 (de) 6-Alkoxy-N-(5-tetrazolyl)-1-oxo-1H-pyrimido-[1,2-a] chinolin-2-carboxamide, Verfahren zu deren Herstellung und dieselben enthaltende antiallergisch wirksame pharmazeutische Zubereitungen
US4636498A (en) Formulation of antiinflammatory drugs
EP0276805B1 (de) Substituierte 3-Phenyl-7H-thiazolo[3,2 -b] [1,2,4]triazin-7-one, Verfahren zu ihrer Herstellung, die sie enthaltenden Arzneimittel und ihre Verwendung, sowie einige bei der Herstellung der genannten Verbindungen gebildete Zwischenprodukte
DE2644121A1 (de) Neue pyridobenzodiazepinone, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4414388A (en) 1-Oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides
DE3413875A1 (de) Benzothiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltendes arzneimittel
CH639389A5 (de) 2,5-dihydro-1,2-thiazino(5,6-b)indol-3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE2452996A1 (de) Neue 4-hydroxy-2h-naphtho- eckige klammer auf 2,1-e eckige klammer zu -1,2thiazin-3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
FI71158B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1-xo-1h-tiazolo/3,2-a/pyrimidin-2-karboxylsyror
DE3400733A1 (de) Substituierte carboxy-thiazolo-(3,2-a)-pyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zubereitungen
CH620217A5 (es)
AT376980B (de) Verfahren zur herstellung neuer pyrido(1,2-a)pyrimidin-derivate, von deren pharmazeutisch akzeptablen salzen sowie deren solvaten, stereoisomeren und tautomeren

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee